Nanotechnology and Alzheimer’s Disease: What has been Done and What to Do’

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|36|4169-4185

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.36, 2014-12, pp. : 4169-4185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What are the Treatment Options for Patients with Severe Alzheimer’s Disease?

By Voisin T.  

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 575-583

Adis International

Access to resources Recommend Favorite

What has the Royal College of Physicians ever done for us?

By Horton Richard  

Clinical Medicine, Vol. 7, Iss. 6, 2007-12 ,pp. : 600-602

Royal College Of Physicians

Access to resources Recommend Favorite

Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

By  

Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. : 22-45

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Small is Beautiful: What Can Nanotechnology Do for Personalized Medicine?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 231-237

Bentham Science Publishers

Access to resources Recommend Favorite